Nigeria hosts one of the largest healthcare training ecosystems in Africa. With dozens of accredited medical schools regulated by the National Universities Commission and Medical and Dental Council of Nigeria, hundreds of nursing, pharmacy and allied health institutions, and major teaching hospitals such as University College Hospital, Ahmadu Bello University Teaching Hospital and Lagos University Teaching Hospital, already serving as referral centres for complex cases within West Africa, and trains thousands of doctors and paramedical professionals, annually. Ironically, Nigeria loses billions of dollars yearly to outbound medical tourism.
While this scenario reflects Nigeria’s inability to retain medical professionals, it presents an opportunity to transform the country from a net exporter of patients and trainees, to Africa’s most affordable, high-quality healthcare hub and centre of excellence in medical research and training.
This ambition has been achieved elsewhere. India overcame weak infrastructure and brain-drain to become a medical tourism powerhouse, with Apollo Hospitals and Fortis Healthcare drawing vast international patients through accreditation, diaspora leverage, and costs far below Western rates. Thailand built global credibility via Joint Commission International (JCI)-certified Bumrungrad International Hospital, combining clinical excellence with hospitality. The United Arab Emirates, especially Dubai, used free zones and incentives to create a regional referral hub. With advantage of English as an official language, a large clinical workforce, and extensive diaspora representation in advanced specialties. Nigeria can strategically replicate and Africanise these models by establishing ‘Special Healthcare Economic Zones’ which will offer import duty waivers on medical equipment, simplified licensing, malpractice insurance frameworks, and research tax credits and holidays.
Transforming Nigeria’s healthcare sector into a continental hub requires a deliberate three-pronged strategy built on infrastructural excellence, diaspora integration, and healthcare industrialisation.
Perhaps, Nigeria’s greatest strategic asset lies abroad. The Nigerian Medical Association and diaspora networks estimate that tens of thousands of Nigerian-trained physicians constitute one of the largest foreign-trained cohorts in the United Kingdom’s National Health Service and hold senior academic and consultant positions across western countries, with many in highly specialised fields. This global faculty network and asset can be mobilised through institutionalised diaspora engagement.
A structured “Return-to-Operate” and “Return-to-Teach” scheme offering streamlined licensing, temporary consultant privileges, research grants, and tax incentives provides a pathway for bringing this high-level expertise home for periodic service and training missions. Even limited annual rotations of 2–8 weeks significantly upgrade local surgical and diagnostic capacity, while partial physical presence combined with virtual case conferences expands knowledge transfer and strengthens local clinical capability.
Nigeria’s healthcare strategy requires the prioritisation of 6–8 world-class, regionally distributed Centres of Excellence as public–private hybrid institutions specialising in cardiology, oncology, neurosurgery, orthopaedics, nephrology and transplantation, fertility, and advanced diagnostics. These centres would pursue Joint Commission International (JCI) or equivalent accreditation to ensure globally benchmarked quality and safety standards that signal credibility to international insurers and patients. Positioned within this framework, Nigeria occupies the “middle tier” or “accessible excellence” segment, offering near-Western standards at significantly lower cost, with cultural proximity and easier visa logistics, thereby capturing a share of the billions of dollars that sub-Saharan Africa loses annually to outbound medical tourism.
Internationally, countries like India, Singapore and the UAE succeeded as healthcare hubs because of investment in research through building clinical trial infrastructure compliant with Good Clinical Practice standards. Nigeria’s large, genetically diverse population makes it attractive for pharmaceutical trials and translational research, with potential to propel it to a continental clinical research leader, once ethical regulations, data systems and laboratory capacity are strengthened. Partnerships between teaching hospitals and global pharmaceutical companies would generate foreign exchange, enhance technology transfer, and elevate academic visibility.
Healthcare is beyond just social spending, but also functions as an export-oriented industry involving pharmaceutical manufacturing, biomedical equipment assembly, digital health start-ups, telemedicine platforms, and regional diagnostic laboratory chains. Nigeria’s entrepreneurial class, with demonstrated capacity to scale complex sectors, is capable of replicating that success in tertiary healthcare through well-capitalised hospital groups operating under global standards.
Universal or near-universal health insurance coverage for the country and the sub-region are essential to build Nigeria’s capacity to act as a regional healthcare hub. A viable domestic insurance market will provide predictable revenue streams for tertiary centres, making large-scale investment worthwhile, while regional ECOWAS insurance portability agreements could enable cross-border care access.
Governance reform and regulation are non-negotiable foundation. Transparent procurement systems, professionalised hospital management, electronic medical records, and zero tolerance for informal payments remain essential pillars of credibility. Quality assurance requires strict enforcement, while regulatory bodies operate more effectively when they move beyond bureaucratic gatekeeping towards performance-based oversight. India and Thailand succeeded largely because of regulatory credibility.
If the aforementioned are executed effectively, the dividends are enormous. Foreign exchange earnings from inbound medical tourism, reduced capital flight from outbound treatment, job creation for highly skilled professionals, expansion of biomedical industries, and retention of top-tier talent would collectively redefine Nigeria’s economic structure.
Nigeria does not need to start from the scratch to build a globally competitive healthcare sector. Nigeria just needs to upgrade and integrate what already exists. The country already produces internationally competitive professionals, trains at scale, and commands regional economic influence. What is required is strategic coherence and coordination. The global healthcare economy is projected to grow steadily over the next decades, just as Africa’s population is expanding, urbanising, and demanding higher-quality care. Nigeria, by virtue of its scale, talent pool, and entrepreneurial energy, is uniquely positioned to lead, and this we must.
